Clinical Trial Update: Study of Voncento® in Subjects With Von Willebrand Disease [Phase 4]

View source ↗

Summary

This entry notes the completion of a Phase 4 clinical trial evaluating Voncento in subjects with Von Willebrand disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Willebrand Disease

Drugs mentioned

• Voncento (Factor VIII/von Willebrand factor concentrate)

Snippet

Sponsor: CSL Behring | Conditions: Von Willebrand Disease | Phase 4 | Status: COMPLETED